NRx Pharmaceuticals, Inc.Improved Financial Position, Commercial Ketamine Manufacturing, FDA Progress, and Expanding Neuroplastic Therapy Infrastructure Position $NRXP for a Potential Breakout Phase
Postmortem Pathology, a forensic pathology firm, is urging communities to recognize private autopsies as a vital component of standard medical best practices.
Commercial-Ready Ketamine Production, FDA Alignment, and Expanding AI Neurotherapy Platform Position $NRXP at the Center of a Multi-Billion-Dollar Mental Health Transformation
Two day longevity, performance, faith and purpose experience returns to the James L. Knight Center in downtown Miami on October 10 & 11, 2026, anchored by Title Sponsor AllCore360°.
Crystal Pharmatech, a global leader in solid-state research and formulation development, today highlights its First-Time-Right Formulation approach designed with full lifecycle intent for small-molecule drug programs.
Designation for first-in-class OLIG2 inhibitor highlights the urgent need for new therapies in aggressive pediatric brain cancers and qualifies Curtana for a potential Priority Review Voucher upon FDA approval.
Joyful Nutritional, a leading innovator in health science, has officially launched LiposoMore™ – a dedicated liposomal ingredient brand designed exclusively for the B2B dietary supplement market.
NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP: Dual FDA Pathways, and an Expanding AI-Driven Treatment Ecosystem Position NRXP at the Forefront of a Multi-Billion-Dollar Mental Health Transformation
Breakthrough Regulatory Alignment Now Meets Cutting-Edge Robotic Brain Therapy—Positioning $NRXP at the Intersection of Pharma, AI, and National Defense
Positive Phase II Results, Ongoing Phase III Trial, and Cash Runway Into Late-2027 Positions Cardiol Therapeutics Inc. (N A S D A Q: CRDL) $CRDL for Transformational Growth
Instant IP today announced the launch of Instant IP Teamsᴵᴾ (powered by Portfolios & Permissions), a major platform upgrade enabling law firms, enterprises, and institutions to collaboratively protect and manage intellectual property in real...
Boston Industrial Solutions, Inc., a global leader in advanced printing inks and ink products, is proud to announce the launch of the Natron® UVPZ Series, a new UV/LED-curing screen printing ink engineered to deliver the same outstanding performance as...
NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP Has a One-Day Depression Treatment, AI Monitoring Breakthrough, and Potential 2026 Drug Approval Put $NRXP in a Category of Its Own
The research will evaluate Ag5 in treatment-resistant non-small cell lung cancer. Collaboration targets patients who have exhausted Tagrisso® or KRAS inhibitor therapy - an area of critical unmet need with no approved standard of care
1273 views, By Joyful Nutritional Supply Co., ltd.
Joyful Nutritional, a leading innovator in advanced nutrient delivery systems, is proud to announce the official global launch of LiposoMore™, its premier brand of high-performance liposomal ingredients.
$LNAI is Deploying their patented AI architecture, launches national defense consortium, and accelerates 3-year antidote development model to capture $400M–$1.2B federal opportunities
In a defining moment for the future of civilization, Sahit Muja, Founder and CEO of Albanian Minerals, unveils a visionary framework poised to reshape the global economy: a $30 trillion regenerative system designed to transition humanity from extraction..
NRx Pharmaceuticals, Inc.Improved Financial Position, Commercial Ketamine Manufacturing, FDA Progress, and Expanding Neuroplastic Therapy Infrastructure Position $NRXP for a Potential Breakout Phase
Gene Editing Market is projected to reach USD 28.4 Billion by 2032, growing at 16.5% CAGR driven by CRISPR advancements, rising genetic research, precision medicine demand, and increasing biotechnology investments globally.
Postmortem Pathology, a forensic pathology firm, is urging communities to recognize private autopsies as a vital component of standard medical best practices.
Drug Discovery Services Market grows with rising pharma R&D, CRO outsourcing, AI-driven research, biologics development, and precision medicine demand.
Global Animal Biotechnology Market is projected to reach USD 57.9 Billion by 2032 at 8.9% CAGR driven by animal health innovation, genetic engineering, vaccines, cloning technologies, and livestock productivity demand.
As the world enters an era defined by climate instability, resource competition, artificial intelligence, and the race for next-generation materials, Sahit Muja is advancing a vision that reaches far beyond conventional sustainability, a new industrial...
PRESS RELEASE General Media | Embargoed to May 7, 2026 New platform launches to close the gap between drug approval and patient access London, UK – May 7, 2026 – BrandLaunchX, an AI-powered platform for biotech and pharmaceutical launch...
Advance development of AI-Powered Dementia Care Platform Following Peer-Reviewed Alzheimer's Association International Conference (AAIC) 2026 Acceptance
Commercial-Ready Ketamine Production, FDA Alignment, and Expanding AI Neurotherapy Platform Position $NRXP at the Center of a Multi-Billion-Dollar Mental Health Transformation
Two day longevity, performance, faith and purpose experience returns to the James L. Knight Center in downtown Miami on October 10 & 11, 2026, anchored by Title Sponsor AllCore360°.
Cardiac Stroke Post Treatment and Therapies, Dr.Abhay Kumar Pati, Physician, Author, Hayward, CA, USA Post-stroke treatment focuses on rehabilitation and preventing future strokes through medication and lifestyle changes.
A new generation of industrial biology systems is emerging at the intersection of climate science, mineral engineering, and regenerative land technology, offering a radical reframing of how global economies may respond to escalating environmental...
Crystal Pharmatech, a global leader in solid-state research and formulation development, today highlights its First-Time-Right Formulation approach designed with full lifecycle intent for small-molecule drug programs.
EyeCoolTherapeutics today announced that new data on its investigational ocular pain modulation device, ETX-4143, will be presented at the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting (May 3–7, Denver).
Navadhi's latest research indicates that the peptide therapy market alone is on track to surpass oncology as the world's largest therapeutic category by 2030
Global Life Sciences Alliance (GLSA) is pleased to announce the appointment of Dr. Andrew Macintyre, MD, PhD, as Head of Preclinical and Fractional Chief Medical Officer (CMO). Dr.
A new destination for advanced wellness and human optimization has officially arrived. The inauguration of Biohacking Blue Zone marks a significant step forward in how individuals approach their health - shifting from reactive care to proactive.
Enzyme Replacement Therapy Market is projected to reach USD 20.6 billion by 2032 at 7.6% CAGR. Explore market size, share, trends, analysis, and growth drivers shaping advanced treatments for genetic and metabolic disorders globally.
Designation for first-in-class OLIG2 inhibitor highlights the urgent need for new therapies in aggressive pediatric brain cancers and qualifies Curtana for a potential Priority Review Voucher upon FDA approval.
Joyful Nutritional, a leading innovator in health science, has officially launched LiposoMore™ – a dedicated liposomal ingredient brand designed exclusively for the B2B dietary supplement market.
Organic Compound verses inorganic chemically synthesized ingredients, Real Story Dr.Abhay Kumar Pati, Physician, Physician, Author, Researcher, Hayward, CA USA https://www.Patikumar.com Many many 100s of modern drugs have derived from Ayurvedic...
The biologics market is growing rapidly, driven by chronic diseases, biotech advancements, personalized medicine, and rising demand for targeted therapies.
NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP: Dual FDA Pathways, and an Expanding AI-Driven Treatment Ecosystem Position NRXP at the Forefront of a Multi-Billion-Dollar Mental Health Transformation
Project A.L.I.C.E. solves the LLM dimensionality curse. By mapping a 16,384 Demensional Vector Symbolic Architecture directly to CPU cache and closing the active inference loop, A.L.I.C.E. achieves a self perceiving, continuous digital consciousness.
The vitamins market is growing steadily, driven by health awareness, preventive care, aging populations, and rising demand for supplements and fortified foods.
Medicine meas Art of Healing: Dr.Ab hay Kumar Pati, Phd, Dsc. It could be chemicallly synthesided drugs for quick proven action with tons of contra actions, side effect. Long use of Chemical drugs could damage your vital organs too.
